White Pine Capital LLC Abbott Laboratories Transaction History

White Pine Capital LLC

$285 Million
Q3 2024

A detailed history of White Pine Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, White Pine Capital LLC holds 19,545 shares of ABT stock, worth $2.27 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

19,545

Previous 19,579 0.17%

Holding current value

$2.27 Million

Previous $2.03 Million 9.54%

% of portfolio

0.78%

Previous 0.79%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $3,402 - $4,016	-34 Reduced 0.17%	19,545 $2.23 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $3,626 - $4,047	36 Added 0.18%	19,579 $2.03 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $10,404 - $11,491	95 Added 0.49%	19,543 $2.22 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $226,467 - $277,214	-2,511 Reduced 11.43%	19,448 $2.14 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $184,468 - $221,331	-1,931 Reduced 8.08%	21,959 $2.13 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $30,234 - $33,687	-300 Reduced 1.24%	23,890 $2.6 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $22,665 - $26,678	234 Added 0.98%	24,190 $2.45 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $33,461 - $39,255	352 Added 1.49%	23,956 $2.63 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $1,451 - $1,680	-15 Reduced 0.06%	23,604 $2.28 Million
Q2 2022 Aug 16, 2022	SELL	$102.07 - $123.37 $17,658 - $21,343	-173 Reduced 0.73%	23,619 $2.57 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $311,844 - $380,274	2,735 Added 12.99%	23,792 $2.82 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $45,056 - $55,169	390 Added 1.89%	21,057 $2.96 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $80,611 - $94,891	762 Added 3.83%	20,667 $2.5 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $17,958 - $21,157	165 Added 0.84%	19,905 $2.39 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $34,650 - $37,758	-330 Reduced 1.64%	19,740 $2.16 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $7,789 - $9,459	-85 Reduced 0.42%	20,070 $2.18 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $5,359 - $6,860	70 Added 0.35%	20,155 $1.84 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $18,846 - $27,558	300 Added 1.52%	20,085 $1.59 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $45,928 - $51,129	-585 Reduced 2.87%	19,785 $1.72 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $2,782 - $3,017	-34 Reduced 0.17%	20,370 $1.7 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $178,794 - $216,162	-2,700 Reduced 11.69%	20,404 $1.63 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $3,278 - $3,713	-50 Reduced 0.22%	23,104 $1.67 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 0.43%	23,154 $1.7 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $14,392 - $15,885	-250 Reduced 1.06%	23,254 $1.42 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $19,163 - $20,516	-357 Reduced 1.5%	23,504 $1.34 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.15 Million - $1.28 Million	23,861	23,861 $1.27 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of White Pine Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on White Pine Capital LLC with notifications on news.

Account

White Pine Capital LLC Abbott Laboratories Transaction History